Arbutus Biopharma Corp - Common Shares, without par value (ABUS)
CUSIP: 03879J100
Q2 2016 13F Holders as of 30 Jun 2016
- Type / Class
- Equity / Common Shares, without par value
- Shares outstanding
- 194,990,877
- Total 13F shares
- 17,549,536
- Share change
- -160,932
- Total reported value
- $61,069,070
- Put/Call ratio
- 234%
- Price per share
- $3.48
- Number of holders
- 47
- Value change
- -$709,869
- Number of buys
- 18
- Number of sells
- 21
Quarterly Holders Quick Answers
What is CUSIP 03879J100?
CUSIP 03879J100 identifies ABUS - Arbutus Biopharma Corp - Common Shares, without par value in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Related Filing Research
- Latest 13F filings for newly reported positions.
- Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
- Latest 10-Q/10-K reports for financial context tied to this issuer.
- Recent insider transactions for executive and insider activity.
- SEC investors directory and top value investors for manager drilldown.
- Back to full security ownership history.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 03879J100:
Top shareholders of ABUS - Arbutus Biopharma Corp - Common Shares, without par value (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| PRIMECAP MANAGEMENT CO/CA/ |
13F
|
Company |
2%
|
3,850,000
|
$15,900,000 | — | 31 Mar 2016 | |
| Alpha Wave Global, LP |
13F
|
Company |
1.3%
|
2,618,000
|
$10,812,000 | — | 31 Mar 2016 | |
| HealthCor Management, L.P. |
13F
|
Company |
1.1%
|
2,229,300
|
$9,207,000 | — | 31 Mar 2016 | |
| D. E. Shaw & Co., Inc. |
13F
|
Company |
0.88%
|
1,711,569
|
$7,069,000 | — | 31 Mar 2016 | |
| SABBY MANAGEMENT, LLC |
13F
|
Company |
0.61%
|
1,197,338
|
$4,945,000 | — | 31 Mar 2016 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.41%
|
797,740
|
$3,295,000 | — | 31 Mar 2016 | |
| BANK OF MONTREAL /CAN/ |
13F
|
Company |
0.41%
|
795,335
|
$3,285,000 | — | 31 Mar 2016 | |
| AXA S.A. |
13F
|
Company |
0.4%
|
781,296
|
$3,227,000 | — | 31 Mar 2016 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.38%
|
748,731
|
$3,092,000 | — | 31 Mar 2016 | |
| SPHERA FUNDS MANAGEMENT LTD. |
13F
|
Company |
0.23%
|
454,500
|
$1,877,000 | — | 31 Mar 2016 | |
| SUFFOLK CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.21%
|
410,892
|
$1,697,000 | — | 31 Mar 2016 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.14%
|
276,800
|
$1,143,000 | — | 31 Mar 2016 | |
| BAILARD, INC. |
13F
|
Company |
0.11%
|
215,000
|
$888,000 | — | 31 Mar 2016 | |
| DIALECTIC CAPITAL MANAGEMENT, LP |
13F
|
Company |
0.1%
|
199,895
|
$825,000 | — | 31 Mar 2016 | |
| BAKER BROS. ADVISORS LP |
13F
|
Company |
0.09%
|
180,582
|
$746,000 | — | 31 Mar 2016 | |
| CREDIT SUISSE AG/ |
13F
|
Company |
0.09%
|
176,150
|
$727,000 | — | 31 Mar 2016 | |
| Bellevue Group AG |
13F
|
Company |
0.06%
|
125,000
|
$516,000 | — | 31 Mar 2016 | |
| DAFNA Capital Management LLC |
13F
|
Company |
0.06%
|
115,230
|
$476,000 | — | 31 Mar 2016 | |
| TFS CAPITAL LLC |
13F
|
Company |
0.05%
|
102,327
|
$423,000 | — | 31 Mar 2016 | |
| MARINER INVESTMENT GROUP LLC |
13F
|
Company |
0.05%
|
89,800
|
$371,000 | — | 31 Mar 2016 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.04%
|
87,073
|
$358,000 | — | 31 Mar 2016 | |
| VANGUARD GROUP INC |
13F
|
Company |
0.04%
|
74,067
|
$306,000 | — | 31 Mar 2016 | |
| AMERIPRISE FINANCIAL INC |
13F
|
Company |
0.03%
|
67,471
|
$279,000 | — | 31 Mar 2016 | |
| VIRTUS ADVISERS, LLC |
13F
|
Company |
0.03%
|
54,471
|
$225,000 | — | 31 Mar 2016 | |
| CAXTON CORP |
13F
|
Company |
0.02%
|
41,903
|
$173,000 | — | 31 Mar 2016 | |
| MORGAN STANLEY |
13F
|
Company |
0.02%
|
40,609
|
$167,000 | — | 31 Mar 2016 | |
| MACKENZIE FINANCIAL CORP |
13F
|
Company |
0.02%
|
39,900
|
$165,000 | — | 31 Mar 2016 | |
| CITIGROUP INC |
13F
|
Company |
0.02%
|
32,860
|
$136,000 | — | 31 Mar 2016 | |
| K2 PRINCIPAL FUND, L.P. |
13F
|
Company |
0.02%
|
29,754
|
$123,000 | — | 31 Mar 2016 | |
| Stanley-Laman Group, Ltd. |
13F
|
Company |
0.01%
|
25,722
|
$106,000 | — | 31 Mar 2016 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.01%
|
20,203
|
$83,000 | — | 31 Mar 2016 | |
| FMR LLC |
13F
|
Company |
0.01%
|
19,200
|
$79,000 | — | 31 Mar 2016 | |
| GROUP ONE TRADING LLC |
13F
|
Company |
0.01%
|
17,456
|
$72,000 | — | 31 Mar 2016 | |
| ROYAL BANK OF CANADA |
13F
|
Company |
0.01%
|
13,590
|
$56,000 | — | 31 Mar 2016 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.01%
|
12,435
|
$51,000 | — | 31 Mar 2016 | |
| STATE STREET CORP |
13F
|
Company |
0.01%
|
12,001
|
$50,000 | — | 31 Mar 2016 | |
| Cutler Group LLC / CA |
13F
|
Company |
0.01%
|
12,080
|
$49,000 | — | 31 Mar 2016 | |
| Alpine Global Management, LLC |
13F
|
Company |
0.01%
|
10,434
|
$43,000 | — | 31 Mar 2016 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0%
|
6,195
|
$25,000 | — | 31 Mar 2016 | |
| SIMPLEX TRADING, LLC |
13F
|
Company |
0%
|
5,861
|
$24,000 | — | 31 Mar 2016 | |
| UBS Group AG |
13F
|
Company |
0%
|
5,733
|
$24,000 | — | 31 Mar 2016 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0%
|
2,995
|
$12,000 | — | 31 Mar 2016 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0%
|
1,850
|
$8,000 | — | 31 Mar 2016 | |
| Creative Planning |
13F
|
Company |
0%
|
1,450
|
$6,000 | — | 31 Mar 2016 | |
| WOODMONT INVESTMENT COUNSEL LLC |
13F
|
Company |
0%
|
800
|
$3,000 | — | 31 Mar 2016 | |
| US BANCORP \DE\ |
13F
|
Company |
0%
|
300
|
$1,000 | — | 31 Mar 2016 | |
| Sonora Investment Management, LLC |
13F
|
Company |
0%
|
20
|
$106 | — | 31 Mar 2016 |
Institutional Holders of Arbutus Biopharma Corp - Common Shares, without par value (ABUS) as of Q2 2016
As of 30 Jun 2016,
Arbutus Biopharma Corp - Common Shares, without par value (ABUS) was held by
47 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
17,549,536 shares.
The largest 10 holders included
PRIMECAP MANAGEMENT CO/CA/, Falcon Edge Capital LP, HealthCor Management, L.P., D. E. Shaw & Co., Inc., SABBY MANAGEMENT, LLC, BANK OF MONTREAL /CAN/, AXA, GOLDMAN SACHS GROUP INC, MILLENNIUM MANAGEMENT LLC, and SUFFOLK CAPITAL MANAGEMENT LLC.
This page lists
47
institutional shareholders reporting positions in this security
for the Q2 2016 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2016 vs Q1 2016 Across Filers
Q1 2016 holders
47
Q2 2016 holders
47
Holder diff
0
| Investor | Q1 2016 Shares | Q2 2016 Shares | Share Diff | Share Chg % | Q1 2016 Value $ | Q2 2016 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.